Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast CancerMatthew P. Humphries, Niamh E. Buckley, Eileen E. Parkes et al.|Journal of Oncology|2018Cited by 63
Quantification of HER2 heterogeneity in breast cancer–implications for identification of sub-dominant clones for personalised treatmentNiamh E. Buckley, Manuel Salto‐Tellez, Claire Forde et al.|Scientific Reports|2016Cited by 50
Molecular classification of non-invasive breast lesions for personalised therapy and chemopreventionNiamh E. Buckley, Manuel Salto‐Tellez, Paul B. Mullan et al.|Oncotarget|2015Cited by 10